Promisia Healthcare Ltd

Promisia Healthcare has a market capitalization of NZD 24.29 million and a price-to-earnings ratio of 3.55, indicating a relatively low valuation compared to earnings. The company's price-to-book ratio of 0.62 suggests that the market values the company at a discount to its book value. The enterprise value to EBITDA ratio of 7.47 and enterprise value to revenue ratio of 2.28 further support a conservative valuation. In terms of profitability, the company's return on equity of 17.41% is strong, but its return on assets of 3.97% is relatively low, indicating that the company is not efficiently utilizing its assets to generate returns. The debt-to-equity ratio of 1.19 suggests a moderate level of leverage, with long-term debt amounting to NZD 46.69 million against total equity of NZD 39.27 million. Promisia Healthcare operates in a single segment focused on aged care in New Zealand. The company's revenue is entirely concentrated within New Zealand, with no disclosed international operations. This geographic concentration may expose the company to local economic and regulatory risks. The company's revenue for the latest period was NZD 31.08 million, with a net income of NZD 6.84 million. The outlook for the current fiscal year indicates a positive growth trajectory, supported by the company's operating cash flow of NZD 3.40 million and free cash flow of NZD 6.70 million. However, the capital expenditure of NZD -0.29 million suggests a reduction in investment in new assets. The risk assessment for Promisia Healthcare indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could impact its ability to meet short-term obligations. The dilution risk is low, with no significant dilution potential identified in the basic shares outstanding. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's latest actual EPS was reported at -0.42 NZD, and the latest actual revenue was reported at 0.00 NZD, which may suggest a need for further analysis of the company's financial reporting practices.